Can Aldactone (spironolactone) cause breast tenderness in men?
Yes. Aldactone (spironolactone) can cause “gynecomastia” (breast enlargement) and related symptoms such as breast tenderness in men. It is a well-known hormonal side effect of spironolactone because the drug affects androgen (male hormone) activity and can increase estrogen effects in the body.
Why does spironolactone cause breast changes?
Spironolactone acts as an androgen receptor blocker and also lowers androgen effects. In men, reduced androgen action can shift the hormone balance toward estrogen effects at the breast tissue level, which can lead to breast swelling and pain/tenderness.
What other symptoms might happen besides tenderness?
Men may also notice breast enlargement and nipple sensitivity. Some people report sexual side effects as well, because spironolactone can affect hormone signaling beyond the breast.
How soon does breast tenderness start, and does it go away?
Breast tenderness from spironolactone can develop after starting the medication, and the timing varies by person. If it’s going to occur, it often shows up within the first weeks to months. Whether it goes away depends on dose, duration of use, and whether the medication is continued.
What can be done if it happens?
If breast tenderness or enlargement develops, clinicians may:
- Reassess the dose.
- Consider switching to an alternative diuretic/anti-androgen strategy (for example, eplerenone is sometimes used instead of spironolactone because it has less anti-androgen effect).
- Check whether symptoms are also from other causes (medication changes, liver/kidney issues, thyroid problems, or other hormone-related conditions).
When should someone call a clinician urgently?
Contact a clinician promptly if there is a lump that is hard or growing quickly, skin changes, nipple discharge (especially bloody), or significant pain, since these need evaluation even if a medication side effect is suspected.
Is this common?
Breast tenderness and gynecomastia are recognized adverse effects of spironolactone in men; they’re common enough to be included in standard prescribing information, though the exact frequency depends on dose and individual sensitivity.
Does eplerenone have the same risk?
Eplerenone is often considered when spironolactone causes hormonal side effects, because it is less likely to cause gynecomastia and breast tenderness than spironolactone. A prescriber can determine whether a switch is appropriate for the patient’s condition.
Sources
No sources were provided in the prompt, so I did not cite any external materials.